// App-Quantinova.ai

M4013 2016 AHA : Lipoprotein(a) is Not Associated With the Risk of Ischemic Cardiovascular Events Following Acute Coronary Syndrome

Researchers

Presenter

  • Christie M Ballantyne

Principal Investigators

  • Philip J Barter

  • Jean-Claude Tardif

  • John Kittelson

  • David Kallend

  • Eran Leitersdorf

  • Lawrence A Leiter

  • John JV McMurray

  • Stephen J Nicholls

  • Anders G Olsson

  • Reynaria Pitts

  • Prediman K Shah

Medical Centers

  • Baylor College of Medicine, Houston, TX

  • Univ of Toronto, St Michael's Hosp, Toronto, ON, Canada

  • South Australian Health and Medical Research Institute, Adelaide, Australia

  • Montreal Heart Institute, Montreal, Quebec, Canada

  • University of Colorado Cancer Center, Aurora, CO

  • Hadassah-Hebrew University, Jerusalem, Israel

  • The Meds Company, Zurich, Switzerland

  • Stockholm Gastro Centre, Stockholm, Sweden

  • VA Medical Ctr and Univ of Colorado Sch of Med, Denver, CO

  • The University of New South Wales, NSW, Australia

  • University of Glasgow, Glasgow, United Kingdom

  • Cedars-Sinai Heart Institute, Los Angeles, CA

Locations

  • Canada

  • Switzerland

  • United Kingdom

  • Australia

  • United States

  • Israel

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Angina

  • Cardiac arrest

  • Diabetes

  • Stroke

Biomarkers

  • Hemoglobin A1c

  • Body mass index

Drug/Treatment

  • Dalcetrapib

Outcome

  • N/A


Study Design

  • observational

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim